[Lilly’s GLP-1 Direct-To-Consumer Move, Changes The “Game Changer” Game](https://wbbsec.com/opinions-and-features/lillys-glp-1-direct-to-consumer-move-changes-the-game-changer-game/)
[Lilly’s GLP-1 Direct-To-Consumer Move, Changes The “Game Changer” Game](https://wbbsec.com/opinions-and-features/lillys-glp-1-direct-to-consumer-move-changes-the-game-changer-game/)
powered by bulletin

Let us be your guide in accessing the capital markets and activating your vision for your company. We have participated in over 250 private and public transactions and have placed $4 billion into a wide array of life sciences companies. We have evaluated a countless number of potential transactions comprehensively, and we approach each transaction we contemplate as a unique opportunity for success. We benefit immensely from our exposure to so many transactions and, working with management teams, we can anticipate how a transaction might be received and what structure is most appropriate to accomplish the goals you establish.

Whether through debt or equity, initial public offerings, secondary offerings, private placements, registered directs, or structured transactions, our team has the knowledge and experience to guide you through the capital formation process through an array of products and services. We will work with you and your team to ensure a financial plan is in place to meet your capital and business objectives.